Metzger Michael A 的 Form 4 申報
Cti Biopharma Corp（CTIC），2022/11/10 申報
- 申報編號
- 0000891293-22-000055
- 申報時間
- 2022/11/10
- 交易日
- 2022/11/8
- 申報延遲
- 2 天
- 10b5-1 計畫
- 表單沒有這欄（2023 年以前）
這份申報列了 5 筆非衍生性交易、2 筆衍生性交易。公開市場賣出合計 $51.1 萬。交易後 2 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Metzger Michael ACIK 0001507220 | 董事 |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2022/11/8 | common stock | M行使選擇權取得 | +28,500 | $0.84 | +$23,940 | 28,500 | 直接 | |
| 2022/11/8 | common stock | M行使選擇權取得 | +63,000 | $1.00 | +$63,000 | 91,500 | 直接 | |
| 2022/11/8 | common stock | S賣出處分 | −50,058 | $5.53F2 | −$276,820.74 | 41,442 | 直接 | |
| 2022/11/8 | common stock | S賣出處分 | −36,942 | $5.65F3 | −$208,722.3 | 4,500 | 直接 | |
| 2022/11/8 | common stock | S賣出處分 | −4,500 | $5.70F4 | −$25,650 | 0 | 直接 |
衍生性證券（表 II）
選擇權、認股權證、限制型股票單位等。股數是標的股票的股數；單價與金額是衍生證券本身的價格，交易後持有是衍生證券的單位數。
| 交易日 | 證券 | 交易 | 標的股數 | 單價 | 金額 | 交易後持有 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2022/11/8 | Common Stock | M行使選擇權處分 | −28,500 | $0.00 | $0 | 0 | 直接 | |
| 2022/11/8 | Common Stock | M行使選擇權處分 | −63,000 | $0.00 | $0 | 63,000 | 直接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F2
Reflects sales of common stock executed in multiple transactions at prices ranging from $ 5.50 to $ 5.59. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
表 I 有 1 筆交易的價格引用這則附註。
- F3
Reflects sales of common stock executed in multiple transactions at prices ranging from $ 5.60 to $ 5.695. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
表 I 有 1 筆交易的價格引用這則附註。
- F4
Reflects sales of common stock executed in multiple transactions at prices ranging from $ 5.70 to $ 5.72. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
表 I 有 1 筆交易的價格引用這則附註。